Neurofibromatosis Life Insurance Options After Being Declined in 2026

If You Have Been Declined, You Are Starting in the Right Place

Being turned down for life insurance because of neurofibromatosis is frustrating, but it is more common than most people realize. Traditional fully underwritten policies involve detailed medical reviews, and conditions like neurofibromatosis raise flags that many carriers simply are not equipped to evaluate favorably. That does not mean coverage is off the table. It means a different path forward exists, and products built for this exact scenario can still put meaningful protection in place for your family.

Why Traditional Underwriting Is Difficult with Neurofibromatosis

Neurofibromatosis involves tumor growth along nerves, and underwriters at many carriers view this as an unpredictable condition. Even when your symptoms are well managed, the potential for progression, surgical interventions, and associated complications creates uncertainty in their risk models. If you have NF1 or NF2, underwriters may focus on the number and location of neurofibromas, any history of malignant transformation, surgical history, and whether you have experienced neurological symptoms. For many carriers, this combination of factors leads to a postponement, a very high table rating, or an outright decline.

This is not a reflection of your overall health or your worth. It is a limitation of how traditional underwriting handles complex genetic conditions. The good news is that other products were created specifically because traditional underwriting does not work for everyone.

Understanding Your Realistic Options

Simplified Issue Life Insurance

Simplified issue policies replace the full medical exam and detailed health records review with a short set of yes or no health questions. There are no blood draws, no attending physician statements, and no months of waiting for underwriting decisions.

Here is what to expect from simplified issue coverage.

• Face amounts typically range from $5,000 to $50,000, with some carriers offering up to $100,000.
• Coverage begins immediately once approved, with no waiting or graded period.
• Premiums are higher per dollar of coverage compared to traditional policies, but approval is far more accessible.
• The health questions vary significantly from one carrier to the next. Some ask broadly about “tumors or growths,” while others use more specific language that may or may not capture neurofibromatosis.

That last point matters enormously. The exact wording of those yes or no questions determines whether you qualify, which is why working with someone who knows the differences between carriers is so valuable.

Graded Benefit Life Insurance

Graded benefit policies have the lowest barrier to entry. Most require only a few basic questions, and some are guaranteed issue with no health questions at all.

The tradeoff is a graded period, typically two to three years, during which the full death benefit is not yet available. If death occurs during this window, your beneficiaries would receive a return of all premiums paid plus interest (often around 10%), rather than the full face amount. After the graded period ends, the full benefit applies.

Graded benefit makes sense when simplified issue is not available or when you want guaranteed acceptance regardless of your diagnosis.

What to Expect on Cost

Let us be straightforward. These policies cost more per dollar of coverage than a traditional term or whole life policy. A $15,000 to $25,000 final expense policy might run $80 to $150 per month depending on your age and the type of product.

That is a real cost. But compare it to the alternative, which is leaving your family with nothing. Funeral expenses alone average over $7,000, and that figure does not include outstanding debts, lost income, or other financial gaps. Even a modest policy removes a significant burden during the hardest moment your family could face.

Why an Independent Agency Matters Even More at This Level

When you are shopping for simplified issue or graded benefit products, the differences between carriers become dramatic. One carrier’s health questionnaire might disqualify you while another’s does not mention your condition at all. Face amounts, graded period lengths, premium structures, and age limits all vary widely.

This is where Insurance By Heroes brings something different to the table. Our agency was founded by a former first responder and military spouse, and every member of our team has a background in public service. That service first mindset means we treat every client’s search with the same dedication we brought to protecting our communities. Because we are an independent agency, we work with many different carriers and can compare simplified issue and graded benefit options side by side. We know which carriers ask which questions, and we can steer your application toward the best possible fit for your specific situation.

You do not have to guess which carrier might say yes. We already know where to look.

Making the Most of Your Options

Even within the simplified issue and graded benefit space, a few things can strengthen your position.

• Having documentation of stable, well managed neurofibromatosis from a specialist helps if a carrier requests any follow up information.
• If your condition is mild with minimal functional impact, some carriers offering simplified issue may be more favorable than you expect.
• Keeping records of your current treatment plan and any imaging that shows stability gives your agent more to work with when matching you to the right product.

One common mistake is deciding to wait. With traditional coverage, waiting sometimes makes sense (for example, allowing time after a surgery for recovery). With simplified issue and graded benefit products, waiting rarely improves your options and may actually reduce them if your health changes or you age into a higher premium bracket. The best time to lock in coverage is now, while your current health status supports it.

If you are ready to see what is available, requesting a quote through Insurance By Heroes costs nothing and puts real numbers in front of you.

FAQ

Can I get life insurance after being declined for neurofibromatosis?

Yes. Simplified issue and graded benefit life insurance products do not use the same underwriting process that led to your decline. Many people with neurofibromatosis qualify for one or both of these policy types.

How much does simplified issue life insurance cost with neurofibromatosis?

Costs depend on your age, the face amount, and the specific carrier. A $15,000 to $25,000 policy might cost between $80 and $150 per month. An independent agent can show you quotes from multiple carriers so you can compare.

What is the difference between simplified issue and graded benefit?

Simplified issue offers immediate full coverage but involves a short health questionnaire that you must pass. Graded benefit has little to no health screening but includes a two to three year waiting period before the full death benefit applies. During that graded period, beneficiaries receive a return of premiums plus interest.

Should I try traditional life insurance again before choosing simplified issue?

In some cases, yes. If your neurofibromatosis is mild and well managed, an experienced independent agent may know of carriers willing to offer traditional coverage with a table rating. It costs nothing to explore that option first, and if it does not work out, simplified issue and graded benefit products remain available as a backup. Working with an agency like Insurance By Heroes that understands both paths saves you time and gives you the clearest picture of every option.

Related health conditions

Readers researching life insurance after a decline often ask whether other conditions face similar underwriting hurdles. These guides cover Low Platelet Count life insurance after being declined, life insurance after a decline involving lipedema, Lactose Intolerance life insurance after being declined, life insurance after a decline involving irregular heartbeat, and life insurance after a decline involving megaureter.